Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Alpha-synuclein' and Ligand = 'BDBM207867'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Alpha-synuclein (Homo sapiens (Human))	BDBM207867 (US9266832, Cpd024) Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(CNC4CCCCC4)c3)c2c1 Show InChI InChI=1S/C24H28ClN3O/c25-20-9-10-23-22(14-20)19(16-28-23)11-12-26-24(29)18-6-4-5-17(13-18)15-27-21-7-2-1-3-8-21/h4-6,9-10,13-14,16,21,27-28H,1-3,7-8,11-12,15H2,(H,26,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	724	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair